Pay in 4 interest-free payments of $9.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Combining PDMP and GNF-2 eliminated transplanted-CML-T315I-mutants in vivo and dose dependently sensitized primary cells from CML T315I patients to GNF-2-induced proliferation inhibition and apoptosis
Molecular Weight: 303
SCH-503034
Dibirdik I
GSK-J1 - H3K27 Histone Demethylases UTX and JMJD3 Inhibitor. CAS# 1373422-53-7 size:2mg solid Combining PDMP and GNF-2 eliminatedGSK J1, CAS No. 1373422 53 7, is the first selective and potent inhibitor of the H3K27 histone demethylases UTX and JMJD3. H3K27 methylations play important roles in regulating gene expression through the polycomb repressive complex (PRC1 or PRC2). This epigenetic mark can be demethylated by lysine demethylase (KDM) UTX and JMJD3, which play important roles in cellular differentiation, development and cancer. In relevant biological assays, GSK J1 was